We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Quantity of Toxin in Stool Correlates with C. difficile Severity

By LabMedica International staff writers
Posted on 25 Oct 2021
Print article
Image: Colored Transmission electron micrograph of Clostridium difficile bacterium forming an endospore (lower right, red oval). Clostridium difficile produce a toxin that irritates the colon and causes diarrhea (Photo courtesy of Kari Lounatmaa, PhD)
Image: Colored Transmission electron micrograph of Clostridium difficile bacterium forming an endospore (lower right, red oval). Clostridium difficile produce a toxin that irritates the colon and causes diarrhea (Photo courtesy of Kari Lounatmaa, PhD)
Clostridioides difficile (syn. Clostridium difficile), also known as C. difficile, or C. diff are Gram-positive species of spore-forming bacteria. Clostridioides spp. are anaerobic, motile bacteria, ubiquitous in nature and especially prevalent in soil. C. difficile cells are Gram-positive and show optimum growth on blood agar at human body temperatures in the absence of oxygen.

Although C. difficile is commonly known as a hospital and antibiotic associated pathogen, at most one third of infections can be traced to transmission from an infected person in hospitals, and only a small number of antibiotics are directly associated with an elevated risk of developing a C. difficile infection (CDI). Pathogenic C. difficile strains produce multiple toxins.

Infectious Disease Specialists at the Beth Israel Deaconess Medical Center (Boston, MA, USA) and their colleagues enrolled 615 hospitalized adults (≥ 18 years) with CDI (acute diarrhea, positive stool Nucleic Acid Amplification Test (NAAT), and decision to treat). Baseline stool toxin A and B concentrations were measured by Simoa Single Molecule Array (Quanterix, Billerica, MA, USA). Subjects were classified by baseline CDI severity (four scoring methods) and outcomes within 40 days (death, ICU stay, colectomy, and recurrence).

The investigators reported that overall, the study showed that across all scoring systems, patients with severe baseline disease had higher stool toxin A and B concentrations than those without. Nineteen subjects (3.1%) had a severe outcome primarily-attributed to CDI (group 1). This group had higher median toxin A+B (14,303 pg/mL) than subjects in whom CDI only contributed to the outcome (group 2, 163.2 pg/mL), subjects with severe outcome unrelated to CDI (group 3, 158.6 pg/mL), or no severe outcome (group 4, 209.5 pg/mL). Group 1 was more likely to have detectable toxin (94.7%) than groups 2-4 (60.5%-66.1%). Individuals with recurrence had higher toxin A+B (2,266.8 pg/mL) than those without (154.0 pg/mL) and higher rates of detectable toxin (85.7% versus 64.0%).

Carolyn D. Alonso, MD, an Assistant Professor of Medicine and first author of the study, and her colleagues said, “This study lays the foundation for developing a highly accurate, single-step test to better diagnose C. difficile infection and predict clinical outcomes. Ultimately, we hope that our research will move the field toward development of a single-step test for C. difficile that can be easily deployed by clinicians without specific expertise in C. difficile diagnosis.”

The authors concluded that in CDI patients, ultrasensitive stool toxin detection and concentration correlated with severe baseline disease, severe CDI-attributable outcomes, and recurrence, confirming the contribution of toxin quantity to disease presentation and clinical course. The study was published on September 19, 2021 in the journal Clinical Infectious Diseases.

Related Links:
Beth Israel Deaconess Medical Center
Quanterix


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.